MAPK14 and colorectal cancer: These findings are very similar to those of Ecn in colorectal cancer cells, that is, Ecn inhibited oxaliplatin-sensitive and -resistant CRCs by activating the p38 signaling pathway, while the p38 inhibitor weakened the inhibitory effects of Ecn.25